Academic Journal

Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication

التفاصيل البيبلوغرافية
العنوان: Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication
المؤلفون: Tirosh Shapira, Selvarani Vimalanathan, Celine Rens, Virginia Pichler, Sandra Peña-Díaz, Grace Jordana, William Rees, Dirk F. H. Winkler, Iqbal Sarai, Theodore Steiner, François Jean, Steven Pelech, Yossef Av-Gay
المصدر: Molecular Biomedicine, Vol 3, Iss 1, Pp 1-13 (2022)
بيانات النشر: Springer, 2022.
سنة النشر: 2022
المجموعة: LCC:Medicine
مصطلحات موضوعية: GSK3β, SARS-CoV-2, Host-directed therapy, Host-pathogen interactions, Antivirals, Medicine
الوصف: Abstract GSK3β has been proposed to have an essential role in Coronaviridae infections. Screening of a targeted library of GSK3β inhibitors against both SARS-CoV-2 and HCoV-229E to identify broad-spectrum anti-Coronaviridae inhibitors resulted in the identification of a high proportion of active compounds with low toxicity to host cells. A selected lead compound, T-1686568, showed low micromolar, dose-dependent activity against SARS-CoV-2 and HCoV-229E. T-1686568 showed efficacy in viral-infected cultured cells and primary 2D organoids. T-1686568 also inhibited SARS-CoV-2 variants of concern Delta and Omicron. Importantly, while inhibition by T-1686568 resulted in the overall reduction of viral load and protein translation, GSK3β inhibition resulted in cellular accumulation of the nucleocapsid protein relative to the spike protein. Following identification of potential phosphorylation sites of Coronaviridae nucleocapsid, protein kinase substrate profiling assays combined with Western blotting analysis of nine host kinases showed that the SARS-CoV-2 nucleocapsid could be phosphorylated by GSK3β and PKCa. GSK3β phosphorylated SARS-CoV-2 nucleocapsid on the S180/S184, S190/S194 and T198 phospho-sites, following previous priming in the adjacent S188, T198 and S206, respectively. Such inhibition presents a compelling target for broad-spectrum anti-Coronaviridae compound development, and underlies the mechanism of action of GSK3β host-directed therapy against this class of obligate intracellular pathogens.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2662-8651
Relation: https://doaj.org/toc/2662-8651
DOI: 10.1186/s43556-022-00111-1
URL الوصول: https://doaj.org/article/7ec5eda2fd154dddb8509d021badac6b
رقم الانضمام: edsdoj.7ec5eda2fd154dddb8509d021badac6b
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:26628651
DOI:10.1186/s43556-022-00111-1